May 16
RVPH · Reviva Pharmaceuticals Holdings, Inc. · Documents
$0.39
+0.04 (+10.76%)
At close · May 14
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year after the date the consolidated financial statements are issued.”View the 10-Q filed Nov 13, 2026
Market Cap
$6.33M
Shares
13.11M
Volume · May 14
742.02K
Avg daily vol (48 sessions)
985.8K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Mar 15
Current report
8-K
Financial results, Regulation FD disclosure
Mar 15
Feb 1
Current report
8-K
Other events
Jan 26
Current report
8-K
Entered into a material agreement
Jan 26
Registration statement
S-3
Registration statement
2021
Dec 10
Current report
8-K
Events of Dec 8
Shareholder vote results
Nov 15
Current report
8-K
Financial results, Regulation FD disclosure
Nov 15
Oct 26
Proxy statement
DEF 14A
Meeting Dec 8, 2021
Proxy statement
Sep 20
Current report
8-K
Events of Sep 17
Shareholder director nominations
Aug 16
Current report
8-K
Financial results, Regulation FD disclosure
Aug 16
Jun 16
Current report
8-K
Events of Jun 15
Director or officer change, or executive pay
May 28
Registration statement
424B4
Registration statement
May 25
Registration statement
S-1/A
Registration statement
May 19
Registration statement
S-1/A
Registration statement
May 17
May 17
Registration statement
424B4
Registration statement
May 10
Current report
8-K
Financial results
May 10
Registration statement
S-1/A
Registration statement
May 7
May 7
Current report
8-K
Financial results, Earlier financial statements no longer reliable
Apr 19
Registration statement
S-1
Registration statement
Apr 15
Current report
8-K
Events of Apr 14
Director or officer change, or executive pay
Mar 29
Registration statement
424B4
Registration statement
Mar 24
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2020
Mar 22
Current report
8-K
Financial results, Regulation FD disclosure
Mar 22
Mar 4
Current report
8-K
Other events
Jan 20
Current report
8-K/A
Events of Dec 14
Change of auditor, Charter or bylaw amendment, or fiscal year change
Jan 14
Jan 12
Registration statement
424B4
Registration statement
Jan 7
Registration statement
S-1/A
Registration statement
2020
Dec 29
Registration statement
S-1
Registration statement
Dec 18
Current report
8-K
Events of Dec 14
Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Change to shareholders' rights, Change of auditor, Change in control, Charter or bylaw amendment, or fiscal year change, Code of ethics change or waiver, Change in shell company status
Dec 14
Current report
8-K
Events of Dec 11
Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Other events
Dec 9
Current report
8-K
Events of Dec 8
Entered into a material agreement, Shareholder vote results
Nov 19
Current report
8-K
Events of Nov 18
Other events
Nov 13
Current report
8-K
Events of Nov 12
New debt or off-balance-sheet obligation
Nov 6
Current report
8-K
Events of Nov 5
Regulation FD disclosure
Nov 6
Registration statement
S-4/A
Registration statement
Nov 5
Current report
8-K
Events of Nov 4
Other events
Nov 3
Registration statement
S-4/A
Registration statement
Oct 27
Current report
8-K
Events of Oct 22
Entered into a material agreement
Oct 22
Current report
8-K
Events of Oct 21
Entered into a material agreement
Oct 14
Oct 6
Current report
8-K
Regulation FD disclosure
Oct 6
Registration statement
S-4/A
Registration statement
Sep 25
Showing 101–150 of 170 documents
Key facts
CIK
1742927
CUSIP
76152G209
13F (30d)
15 filings
4 filers
Visit website
Investor relations